ZBIO
Zenas BioPharma, Inc.
$28.24
-1.17 (-3.98%)
At close · Jul 16
Going-concern doubt
— cleared May 13, 2026
The latest filing states the doubt was alleviated.
“During the first quarter of 2026, the Company alleviated the uncertainty associated with its ability to continue as a going concern through the execution of its senior secured term loan, the issuance of convertible senior notes and the concurrent equity offering”View the 10-Q filed May 13, 2026
Market Cap
$1.78B
Shares
63,133,377
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-13 | 2026-05-11 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-03-31 | 2026-03-26 | |
| DEF 14A | 2026-03-16 | 2026-05-11 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-02-13 | 2026-02-10 | |
| 8-K | 2026-01-05 | — | |
| 8-K | 2025-12-15 | 2025-12-10 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-10-08 | 2025-10-07 | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-06-04 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| DEF 14A | 2025-04-28 | 2025-06-10 | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-02-05 | — | |
| 8-K | 2024-12-02 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-16 | — |
Showing 1–27 of 27 filings